Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Filter Results By

Filter Applied. Clear All
Reset All Filters

Search Results for: fetal tissue cell lines >

Q&A with the Scholars: Science, Ethics, and Fetal Tissue

Tara Sander Lee, Ph.D., is a Molecular and Cell Biologist with over 15 years of experience in academic research and healthcare. She obtained her Ph.D. in biochemistry from the Medical College of Wisconsin, followed by research fellowship training in cell and molecular biology at Harvard Medical Scho...

Backgrounder: We Need a New NIH Director

On April 25, 2017, Charlotte Lozier Institute Vice President and Director of Research, Dr. David A. Prentice, Ph.D., was published in USA Today on the need for a new National Institutes of Health (NIH) Director. The backgrounder below provides summary main points and sources on the position of curre...

Maryland Joins the Trend for Ethical Stem Cell Research

This paper continues the investigation of stem cell research funding in the United States by examining the funding patterns at the Maryland Stem Cell Research Commission. This investigation reveals that the Maryland Commission is keeping with the trend of investing more money in ethical stem cell r...

Federal Bioethics Commissions and Bias Against the Unborn

In August, the Trump administration’s new Human Fetal Tissue Research Ethics Advisory Board reviewed requests made to the National Institutes of Health (NIH) for federally funded fetal tissue research. The Board recommended denying most of these requests.

Stopping the Pain and Saving Lives: Successful Treatments for Sickle Cell Disease

The U.S. Food and Drug Administration (FDA) recently approved not just one, but two new gene therapies for sickle cell disease. The success of adult stem cell therapies continues to demonstrate that the progress of science and medicine need not rely on ethically compromised research and treatment ap...

Minnesota Court Rules in Favor of University’s Use of Aborted Fetal Tissue for Research

There is a great need within the scientific community for transparency, movement away from the gruesome practice of using aborted baby parts for research, and movement toward more advanced and ethical science that is leading to real cures.

Fact Sheet: Adult Stem Cell Research and Transplants

Well over 1 million patients worldwide have been treated with adult stem cells and experienced improved health, based on data gathered by December 2012.

Near Absence of Embryonic Stem Cells in California Clinical Trial Program

In 2013, the California Institute for Regenerative Medicine (CIRM) – the nation’s largest funder of stem cell research outside of the federal government – authorized a new program, the Alpha Stem Cell Clinics Network.